In 2023, Devdatt Kurdikar earned $2.20M in total compensation at Embecta Corp., including $863.46K salary and $1.26M bonus. Most recently acquired 187,166 shares in Nov 2024. Currently holds stock worth $9.06M. 3+ years at the helm of Embecta Corp..
Compensation History
Annual executive compensation data for Devdatt Kurdikar, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$2.20M
Salary
$863.46K
Bonus
$1.26M
Other
$69.75K
Salary
$863.46KBoard Justification
Embecta's compensation philosophy is designed to align the interests of executive officers with those of stockholders by providing pay that is directly linked to the achievement of performance goals established to foster the creation of sustainable long-term stockholder value.
Bonus
$1.26MBoard Justification
The annual incentive award earned under the Bonus Plan for fiscal year 2023, based on performance against pre-established objectives.
Other Compensation
$69.75KBoard Justification
Includes employer contributions to 401(k) and DCP plans, and other compensation elements.
Restricted Stock
Board Justification
No stock awards vested in 2023, as the amounts reported in the Summary Compensation Table reflect the aggregate accounting value of stock awards granted, not those that vested.
Performance Metrics
Performance metrics for 2023 included financial metrics such as Constant Currency Revenue and Adjusted EBITDA, along with strategic objectives.
Devdatt Kurdikar
CEO of Embecta Corp.
Education
Ph.D. in Chemical Engineering from Purdue University, MBA from Washington University in St. Louis.
Field of Expertise
Technology & Engineering - Engineering
Sector of Economy
Healthcare
Born
January 1, 1968 - 57 years ago
CEO of Embecta Corp. for
3 years 8 months (Apr 2022 - Present)
Previous Experience
Worldwide President of Diabetes Care at BD, President and CEO of Cardiac Science Corporation, Vice President and General Manager at Boston Scientific.
Holdings
Track Devdatt Kurdikar's stock holdings and portfolio value over time.
Insider Trading
Devdatt Kurdikar's recent stock transactions, purchases, and sales filed with the SEC.
187,166 shares
EMBC
Nov 26, 2024
Received
178,674 shares
EMBC
Nov 26, 2023
Received
$109.05K
EMBC at $21.81/share
Aug 10, 2023
Purchase
83,233 shares
EMBC
Nov 26, 2022
Received
91,171 shares
EMBC
Apr 4, 2022
Received
98,903 shares
EMBC
Apr 1, 2022
Received
Rivals
Compare Devdatt Kurdikar with competitor CEOs and industry peers.